Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 10,117 | 401 | 17 | 234 |
| Marketable Securities | N/A | 616 | N/A | N/A |
| TOTAL | $10,171 | $1,032 | $20 | $235 |
| Non-Current Assets | ||||
| PPE Net | 204 | 190 | 13 | 8 |
| Investments And Advances | 0 | 0 | 25 | 35 |
| Intangibles | 340 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 63 | 17 |
| TOTAL | $544 | $190 | $100 | $59 |
| Total Assets | $10,715 | $1,222 | $120 | $294 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 760 | 436 | 43 | 7 |
| Accrued Expenses | N/A | N/A | 4 | 4 |
| TOTAL | $760 | $436 | $47 | $10 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 3,850 | 0 | 0 | 0 |
| TOTAL | $5,125 | $1,350 | $N/A | $N/A |
| Total Liabilities | $5,885 | $1,786 | $47 | $10 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 97 | 603 | N/A | N/A |
| Common Shares | 5 | 76 | 29 | 1 |
| Retained earnings | -14,204 | -7,855 | -374 | -206 |
| Other shareholders' equity | 0 | 0 | -39 | 23 |
| TOTAL | $4,830 | $-564 | $73 | $284 |
| Total Liabilities And Equity | $10,715 | $1,222 | $120 | $294 |